Evidence map›Paper›PMID 38311779›Full record

ArticleActa neuropathologica communications2024

Dysregulation of stress granule dynamics by DCTN1 deficiency exacerbates TDP-43 pathology in Drosophila models of ALS/FTD.

Tetsuhiro Ueda, Toshihide Takeuchi, Nobuhiro Fujikake, Mari Suzuki, Eiko N Minakawa, Morio Ueyama, Yuzo Fujino, Nobuyuki Kimura, Seiichi Nagano, Akio Yokoseki and 5 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. TSC2 is a stress granule suppressor.bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. PolyQ-Expansion of Ataxin-2 Disrupts Microtubule Stability and Impairs Axon Outgrowth.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. A Novel De Novo Missense Mutation inInternational journal of molecular sciences · 2024
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Tetsuhiro Ueda *Department of Neurology, Faculty of Medicine, Kindai University, 377-2 Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan.
Toshihide Takeuchi *Life Science Research Institute, Kindai University, 377-2 Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan. takeuchi@med.kindai.ac.jp.ORCID 0000-0002-6236-8009
Nobuhiro FujikakeDepartment of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, 187-8502, Japan.
Mari SuzukiDepartment of Neurotherapeutics, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan.
Eiko N MinakawaDepartment of Neurophysiology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, 187-8502, Japan.
Morio UeyamaDepartment of Neurology, Faculty of Medicine, Kindai University, 377-2 Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan.
Yuzo FujinoDepartment of Neurology, Faculty of Medicine, Kindai University, 377-2 Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan.
Nobuyuki KimuraDepartment of Veterinary Associated Science, Faculty of Veterinary Medicine, Okayama University of Science, Ehime, 794-8555, Japan.
Seiichi NaganoDepartment of Neurotherapeutics, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan.
Akio YokosekiDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, 951-8585, Japan.
Osamu OnoderaDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, 951-8585, Japan.
Hideki MochizukiDepartment of Neurology, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan.
Toshiki MizunoDepartment of Neurology, Kyoto Prefectural University of Medicine, Kyoto, 602-0841, Japan.
Keiji WadaDepartment of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, 187-8502, Japan.
Yoshitaka NagaiDepartment of Neurology, Faculty of Medicine, Kindai University, 377-2 Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan. yoshi.nagai@med.kindai.ac.jp.
National Center of Neurology and Psychiatry · JPKyoto Prefectural University of Medicine · JPNiigata University · JPThe University of Osaka · JPOkayama University of Science · JPOsaka University of Pharmaceutical Sciences · JP

Funding

Human Frontier Science Program RGY0066/2017Japan Agency for Medical Research and Development JP15dm0107026Japan Agency for Medical Research and Development JP16ek0109018Japan Agency for Medical Research and Development JP19ek0109222Japan Agency for Medical Research and Development JP20dm0107061Japan Agency for Medical Research and Development JP20ek0109316Japan Society for the Promotion of Science 11013026Japan Society for the Promotion of Science 17H05699Japan Society for the Promotion of Science 20H05927Japan Society for the Promotion of Science 21H02840Japan Society for the Promotion of Science 22H02792Japan Society for the Promotion of Science 24659438Precursory Research for Embryonic Science and Technology JPMJPR17H8
6 · The paper itself

Abstract

The abnormal aggregation of TDP-43 into cytoplasmic inclusions in affected neurons is a major pathological hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Although TDP-43 is aberrantly accumulated in the neurons of most patients with sporadic ALS/FTD and other TDP-43 proteinopathies, how TDP-43 forms cytoplasmic aggregates remains unknown. In this study, we show that a deficiency in DCTN1, a subunit of the microtubule-associated motor protein complex dynactin, perturbs the dynamics of stress granules and drives the formation of TDP-43 cytoplasmic aggregation in cultured cells, leading to the exacerbation of TDP-43 pathology and neurodegeneration in vivo. We demonstrated using a Drosophila model of ALS/FTD that genetic knockdown of DCTN1 accelerates the formation of ubiquitin-positive cytoplasmic inclusions of TDP-43. Knockdown of components of other microtubule-associated motor protein complexes, including dynein and kinesin, also increased the formation of TDP-43 inclusions, indicating that intracellular transport along microtubules plays a key role in TDP-43 pathology. Notably, DCTN1 knockdown delayed the disassembly of stress granules in stressed cells, leading to an increase in the formation of pathological cytoplasmic inclusions of TDP-43. Our results indicate that a deficiency in DCTN1, as well as disruption of intracellular transport along microtubules, is a modifier that drives the formation of TDP-43 pathology through the dysregulation of stress granule dynamics.

Indexed as

Amyotrophic Lateral SclerosisDNA-Binding ProteinsDrosophila ProteinsDynactin ComplexFrontotemporal DementiaAnimalsDrosophilaHumansStress GranulesDNA-Binding ProteinsDrosophila ProteinsDynactin ComplexTBPH protein, DrosophilaAggregationDCTN1Microtubule-dependent transportStress granuleTDP-43

Identifiers

PMID38311779
PMCPMC10840176
OpenAlexW4391519566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.